This is a non-core endpoint: only basic statistics are computed.
Arthropathy in neoplastic disease
DOID EFO MESH SNOMED Endpoint Browser
ARTHROPATHY_NEOPLASM
arthritis: An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
M36.1*, M36.1*C90.0, M36.1*C96.1
Cause of death: ICD-10
M36.1*, M36.1*C90.0, M36.1*C96.1
2 out of 7 registries used, show all original rules.
20
Check minimum number of events None
20
Include endpoints None
20
Remove individuals based on genotype QC
19
ARTHROPATHY_NEOPLASM
Control definitions
Control exclude
SYSTINOTH_FG
Extra metadata
First used in FinnGen datafreeze
DF2
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Arthropathy in neoplastic disease
based on the number of shared cases.
Broader endpoints:
- Systemic disorders of connective tissue in diseases classified elsewhere (FG)
- Systemic disorders of connective tissue in diseases classified elsewhere
- Other systemic involvement of connective tissue
- Systemic connective tissue disorders
- Finngen Rheumatological endpoints
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 19 | 8 | 11 |
| Unadjusted prevalence (%) | 0.00 | 0.00 | 0.01 |
| Mean age at first event (years) | 67.51 | 68.63 | 66.70 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: ARTHROPATHY_NEOPLASM – Arthropathy in neoplastic disease
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Arthropathy in neoplastic disease
↥Endpoint not on priority list, no data to show.